Rick Berke, executive editor of Stat, talks about the title’s strategy to make health, medicine and life sciences content compelling and deliver this news to a general audience.
Why drug companies need to go from reactive to proactive on pricing
Drug pricing has been in the spotlight since early this fall, thanks to Turing Pharmaceuticals and Martin Shkreli. One thing pharma companies can do is to communicate more proactively.